1. Home
  2. COLL vs LEG Comparison

COLL vs LEG Comparison

Compare COLL & LEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • LEG
  • Stock Information
  • Founded
  • COLL 2002
  • LEG 1883
  • Country
  • COLL United States
  • LEG United States
  • Employees
  • COLL 357
  • LEG N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • LEG Home Furnishings
  • Sector
  • COLL Health Care
  • LEG Consumer Discretionary
  • Exchange
  • COLL Nasdaq
  • LEG Nasdaq
  • Market Cap
  • COLL 1.1B
  • LEG 1.2B
  • IPO Year
  • COLL 2015
  • LEG N/A
  • Fundamental
  • Price
  • COLL $34.62
  • LEG $9.76
  • Analyst Decision
  • COLL Strong Buy
  • LEG Hold
  • Analyst Count
  • COLL 4
  • LEG 4
  • Target Price
  • COLL $44.25
  • LEG $10.00
  • AVG Volume (30 Days)
  • COLL 319.8K
  • LEG 1.6M
  • Earning Date
  • COLL 11-06-2025
  • LEG 10-27-2025
  • Dividend Yield
  • COLL N/A
  • LEG 1.99%
  • EPS Growth
  • COLL N/A
  • LEG N/A
  • EPS
  • COLL 1.06
  • LEG 1.61
  • Revenue
  • COLL $707,007,000.00
  • LEG $4,172,899,999.00
  • Revenue This Year
  • COLL $21.29
  • LEG N/A
  • Revenue Next Year
  • COLL $3.36
  • LEG N/A
  • P/E Ratio
  • COLL $32.88
  • LEG $6.24
  • Revenue Growth
  • COLL 22.61
  • LEG N/A
  • 52 Week Low
  • COLL $23.23
  • LEG $6.48
  • 52 Week High
  • COLL $39.95
  • LEG $13.20
  • Technical
  • Relative Strength Index (RSI)
  • COLL 49.72
  • LEG 57.81
  • Support Level
  • COLL $34.46
  • LEG $9.07
  • Resistance Level
  • COLL $35.90
  • LEG $10.73
  • Average True Range (ATR)
  • COLL 0.97
  • LEG 0.36
  • MACD
  • COLL 0.19
  • LEG 0.15
  • Stochastic Oscillator
  • COLL 69.18
  • LEG 59.21

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About LEG Leggett & Platt Incorporated

Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.

Share on Social Networks: